Nike's Turnaround Progresses Slowly Amid Persistent Margin Pressure and China Headwinds

What happened

Nike's Q3 FY2026 results showed revenue holding flat at $11.28 billion but net income plunging 35% year-over-year to $520 million, highlighting ongoing profitability struggles. Gross margin contracted 130 basis points to 40.2%, primarily due to higher tariffs in North America and elevated markdowns as management clears excess inventory. Management explicitly stated that digital sales remain too promotional and that negative impacts from Greater China will persist throughout fiscal 2027, extending the recovery timeline. While wholesale revenues rebounded with Nike re-engaging retailers like Amazon, digital sales declined, reflecting normalization in consumer behavior and ongoing challenges in direct-to-consumer execution. External analysis corroborates that weak margins, China declines, and strategic missteps mean meaningful financial improvement is likely delayed, undermining near-term optimism.

Implication

Nike's current stock price embeds an optimistic recovery narrative that conflicts with management's guidance for extended margin pressure from tariffs and promotions, creating no margin of safety. The high P/E ratio of 34.7x is unsustainable without near-term gross margin expansion, which requires visible reductions in promotional intensity and tariff drag over the next two to three quarters. China's structural challenges and declining digital sales further erode earnings visibility, making the base-case valuation of $50 per share vulnerable to downside risks. Investors must monitor inventory levels below $7.5 billion and management's shift away from describing 'elevated markdowns' as key signals for any potential entry. Until then, the risk-reward favors patience, with the DeepValue report's 'WAIT' rating reinforced by the article's emphasis on a longer turnaround horizon.

Thesis delta

The new article confirms the DeepValue report's assessment that Nike's turnaround is extended, with weak margins and China issues delaying financial recovery, offering no new catalysts to alter the 'WAIT' rating. Investors should still seek evidence of shrinking tariff drag and promotional easing before considering an investment, as the thesis remains unchanged but with heightened urgency for monitoring operational milestones.